Long-term clinical outcomes of patients with unprotected left main bifurcation lesions treated with 2-stent techniques

Chinese Medical Journal

Volumn 126, Issue 13, 2013, Pages 2409-2413

  Pei, Han Jun ^a   Sui, Yong Gang ^a   Wu, Yong Jian ^a   Yang, Yue Jin ^a   Xu, Bo ^a   Chen, Ji Lin ^a   Qiao, Shu Bin ^a   Li, Jian Jun ^a   Qin, Xue Wen ^a   Yao, Min ^a   Yuan, Jin Qing ^a   Chen, Jue ^a   Liu, Hai Bo ^a   You, Shi Jie ^a   Gao, Run Lin ^a  

^a FUWAI HOSPITAL   (China)

Author keywords

Bifurcations; Left main coronary disease; Percutaneous coronary intervention

Indexed keywords

ADULT; AGED; ANGIOGRAPHY; ARTICLE; CORONARY BIFURCATION LESION; CORONARY STENT; FEMALE; FOLLOW UP; HEART DISEASE; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; IN-STENT RESTENOSIS; INCIDENCE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; SURVIVAL; SYNTAX SCORE;

ADULT; AGED; AGED, 80 AND OVER; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; TIME FACTORS; TREATMENT OUTCOME;

EID: 84879729969     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.20123460     Document Type: Article

References (21)

1. Smith S, Feldman T, Hirshfeld J, Jacobs A, Kern M, King S, et al. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). J Am Coll Cardiol 2006; 47: 1-121.
2. Patel M, Dehmer G, Hirshfeld J, Smith P, Spertus J. ACCF/ SCAI/STS/AATS/AHA/ASNC 2012 appropriateness criteria for coronary revascularization. J Am Coll Cardiol 2012; 59: 857-881.
3. Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. J Am Coll Cardiol 2011; 58: e44-e122.
4. Biondi-Zoccai GG, Lotrionte M, Moretti C, Meliga E, Agostoni P, Valgimigli M, et al. A collaborative systematic review and meta-analysis on 1278 patients undergoing percutaneous drugeluting stenting for unprotected left main coronary artery disease. Am Heart J 2008; 155: 274-283.
5. Valgimigli M, Malagutti P, Aoki J, Garcia-Garcia HM, Rodriguez Granillo GA, van Mieghem CA, et al. Sirolimuseluting versus paclitaxel-eluting stent implantation for the percutaneous treatment of left main coronary artery disease: a combined RESEARCH and T-SEARCH long term analysis. J Am Coll Cardiol 2006; 47: 507-514.
6. Tamburino C, Angiolillo DJ, Capranzano P, Di Salvo M, Ussia G, La Manna A, et al. Long-term clinical outcomes after drugeluting stent implantation in unprotected left main coronary artery disease. Catheter Cardiovasc Interv 2009; 73: 291-298.
7. Meliga E, Garcia-Garcia HM, Valgimigli M, Chieffo A, Biondi-Zoccai G, Maree AO, et al. DELFT (Drug Eluting stent for LeFT main) Registry. Longest available clinical outcomes after drugeluting stent implantation for unprotected left main coronary artery disease: the DELFT (Drug Eluting stent for LeFT main) Registry. J Am Coll Cardiol 2008; 51: 2212-2219.
8. Seung KB, Park DW, Kim YH, Lee SW, Lee CW, Hong MK, et al. Stents versus coronary-artery bypass grafting for the left main coronary artery disease. N Engl J Med 2008; 358: 1781-1792.
9. Buszman P, Kiesz SR, Bochenek A, Peszek-Przybyla E, Szkrobka I, Debinski M, et al. Acute and late outcomes of unprotected left main stenting in comparison with surgical revascularization. J Am Coll Cardiol 2008; 51: 538-545.
10. Serruys PW, Morice MC, Kappetein AP, Colombo A, Holmes DR, Mack MJ, et al. The SYNTAX Investigators. Percutaneous coronary intervention versus coronary artery bypass grafting for severe coronary artery disease. N Engl J Med 2009; 360: 961-972.
11. Kim YH, Park SW, Hong MK, Park DW, Park KM, Lee BK, et al. Comparison of simple and complex stenting techniques in the treatment of unprotected left main coronary artery bifurcation stenosis. Am J Cardiol 2006; 97: 1597-1601.
12. Valgimigli M, Malagutti P, Rodriguez Granillo GA, Tsuchida K, Garcia-Garcia HM, van Mieghem CA, et al. Single-vessel versus bifurcation stenting for the treatment of distal left main coronary artery disease in the drug-eluting stenting era: clinical and angiographic insights into the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) and Taxus-Stent Evaluated at Rotterdam Cardiology Hospital (T-SEARCH) registries. Am Heart J 2006; 152: 896-902.
13. Palmerini T, Sangiorgi D, Marzocchi A, Tamburino C, Sheiban I, Margheri M, et al. Ostial and midshaft lesions vs. bifurcation lesions in 1111 patients with unprotected left main coronary artery stenosis treated with drug-eluting stents: results of the survey from the Italian Society of Invasive Cardiology. Eur Heart J 2009; 30: 2087-2094.
14. Thomas M, Hildick-Smith D, Louvard Y, Albiero R, Darremont O, Stankovic G, et al. Percutaneous coronary intervention for bifurcation disease. A consensus view from the first meeting of the European Bifurcation Club. Eurointervention 2006; 2: 149-153.
15. Colombo A, Stankovic G, Orlic D, Corvaja N, Liistro F, Airodi F, et al. Modified T-stenting technique with crushing for bifurcation lesions: immediate results and 30-day outcome. Cathet Cardiovasc Interv 2003; 60: 145-151.
16. Iakovou I, Ge L, Colombo A. Contemporary stent treatment of coronary bifurcations. J Am Coll Cardiol 2005; 46: 1446-1455.
17. Tamburino C, Capranzano P, Capodanno D, Tagliareni F, Biondi-Zoccai G, Sanfilippo A, et al. Plaque distribution patterns in distal left main coronary artery to predict outcomes after stent implantation. JACC Cardiovasc Interv 2010; 3: 624-631.
18. Kappetein AP, Mohr FW, Feldman TE, Morice MC, Holmes DR, Ståhle E, et al. Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or threevessel disease: 3-year follow-up of the SYNTAX trial. Eur Heart J 2011; 17: 2125-2134.
19. Sheiban I, Sillano D, Biondi-Zoccai G, Chieffo A, Colombo A, Vecchio S, et al. Incidence and management of restenosis after treatment of unprotected left main disease with drug-eluting stents: 70 restenotic cases from a cohort of 718 patients: FAILS (Failure in Left Main Study). J Am Coll Cardiol 2009; 54: 1131-1136.
20. Chen SL, Xu B, Mintz G, Ye F, Zhang JJ, Kan J, et al. Clinical outcome after management of unprotected left main in-stent restenosis after bare metal or drug-eluting stents. Chin Med J 2010; 123: 794-799.
21. Lee JY, Park DW, Kim YH, Yun SC, Kim WJ, Kang SJ, et al. Incidence, predictors, treatment, and long-term prognosis of patients with restenosis after drug-eluting stent implantation for unprotected left main coronary artery disease. J Am Coll Cardiol 2011; 57: 1349-1358.